It’s been a while since we’ve posted something new, but don’t take that to mean nothing’s going on at NSIV! Our member companies and graduates have been continuing to make waves in the news.
NSIV member Cellanyx hit the crowdfunding ground running and captured the attention of MedCity News with their desire to get people involved in their quest to find better screening methods for prostate cancer.
NSIV Graduate, Arctic Sand announced they have closed $9.6 Million in venture capital. The story was picked up in a number of news sources, from Venture Beat, to the Boston Globe, to ElectronicsWeekly.com among others.
Finally, NSIV member company, HepatoChem™ has teamed up with United States Biological to offer the MetaboLyte™ Kit Production Platform which dramatically speeds up metabolite study.
Leave a Comment